ArticleExperimental and therapeutic medicine2023

BP‑1‑102 exerts antitumor effects on T‑cell acute lymphoblastic leukemia cells by suppressing the JAK2/STAT3/c‑Myc signaling pathway.

Can Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.